FundedStartupsDaily / HealthTech / Araceli Biosciences

Araceli Biosciences raises $4.5M

Araceli Biosciences announced a Stage undisclosed round of $4.5M on 13 November 2026. The company operates in HealthTech and is based in United States. Announced 5 days ago.

Raised
$4.5M
Stage
Stage undisclosed
Industry
HealthTech
Country
United States

Outreach angles

  • -Araceli Biosciences is a Tigard, Oregon startup selling instruments and software that image cells and automate their analysis.
  • -Its users include the Max Planck Institute, Evotec, Ginkgo Bioworks and large pharmaceutical companies.
  • -The $4.5M round, with Jeff Swickard joining as an investor, funds commercialisation and new products for human-cell alternatives to animal testing, taking total funding to $22.7M.

Signals

HealthcareHardwareB2B

Round details

Company: Araceli Biosciences
Domain: aracelibio.com
Amount: $4.5M
Stage: Stage undisclosed
Industry: HealthTech
Country: United States
Announced: 13 November 2026
Source: announcement

Other HealthTech raises

Recently funded in United States